Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Operating Expenses | 368 | 484 | 409 | 394 | 563 |
| Operating Income | -368 | -484 | -409 | -394 | -563 |
| Interest Expense | 2 | 0 | 0 | N/A | 0 |
| Other Income | 2 | -5 | 7 | 1 | 0 |
| Pre-tax Income | -369 | -488 | -402 | -393 | -563 |
| Net Income Continuous | -369 | -488 | -402 | -393 | -563 |
| Net Income | $-369 | $-488 | $-402 | $-393 | $-563 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EBITDA(a) | $-204 | $-364 | $-277 | $-269 | $-201 |